Article info
PDFEditorial
Valproate and childbearing potential: new regulations
- Correspondence to Professor Sanjay M Sisodiya, Department of Clinical and Experimental, UCL Institute of Neurology, London WC1N 3BG, UK; s.sisodiya{at}ucl.ac.uk
Citation
Valproate and childbearing potential: new regulations
Publication history
- Accepted March 20, 2018
- First published April 23, 2018.
Online issue publication
June 01, 2018
Article Versions
- Previous version (1 June 2018).
- Previous version (1 June 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Other content recommended for you
- Weighing the risks of valproate in women who could become pregnant
- Impact of regulatory safety notices on valproate prescribing and pregnancy outcome among women of child-bearing potential in Scotland: a population-based cohort study
- Women’s health in focus: Real-world data on valproate prescriptions during pregnancy – a cohort study in Catalonia (Spain)
- Use of prescribing indicators as a means of identifying variation in the prevalence of valproate prescribing between health communities: a cross-sectional study
- Safety update: valproate safety and educational materials
- Preconception counselling in women with epilepsy
- Trends in antiepileptic drug treatment and effectiveness in clinical practice in England from 2003 to 2016: a retrospective cohort study using electronic medical records
- Valproate pregnancy prevention scheme: what are the barriers to enrolling patients and how do we meet them?
- Restricting valproate prescribing in men: wisdom or folly?
- Epilepsies in children, young people, and adults: summary of updated NICE guidance